- Home
- ATRC vs CLDX Comparison
ATRC vs CLDX Comparison
Compare ATRC & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATRC
- CLDX
- Stock Information
- Founded
- ATRC 2000
- CLDX N/A
- Country
- ATRC United States
- CLDX United States
- Employees
- ATRC N/A
- CLDX N/A
- Industry
- ATRC Medical/Dental Instruments
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- ATRC Health Care
- CLDX Health Care
- Exchange
- ATRC Nasdaq
- CLDX Nasdaq
- Market Cap
- ATRC 1.7B
- CLDX 1.6B
- IPO Year
- ATRC 2005
- CLDX 2008
- Fundamental
- Price
- ATRC $34.09
- CLDX $26.22
- Analyst Decision
- ATRC Strong Buy
- CLDX Strong Buy
- Analyst Count
- ATRC 10
- CLDX 8
- Target Price
- ATRC $49.60
- CLDX $46.13
- AVG Volume (30 Days)
- ATRC 405.2K
- CLDX 1.1M
- Earning Date
- ATRC 10-28-2025
- CLDX 11-05-2025
- Dividend Yield
- ATRC N/A
- CLDX N/A
- EPS Growth
- ATRC N/A
- CLDX N/A
- EPS
- ATRC N/A
- CLDX N/A
- Revenue
- ATRC $499,946,000.00
- CLDX $5,790,000.00
- Revenue This Year
- ATRC $16.32
- CLDX N/A
- Revenue Next Year
- ATRC $12.37
- CLDX N/A
- P/E Ratio
- ATRC N/A
- CLDX N/A
- Revenue Growth
- ATRC 16.28
- CLDX N/A
- 52 Week Low
- ATRC $25.57
- CLDX $14.40
- 52 Week High
- ATRC $43.11
- CLDX $31.66
- Technical
- Relative Strength Index (RSI)
- ATRC 42.71
- CLDX 60.30
- Support Level
- ATRC $33.45
- CLDX $24.49
- Resistance Level
- ATRC $35.76
- CLDX $26.90
- Average True Range (ATR)
- ATRC 1.20
- CLDX 1.00
- MACD
- ATRC -0.21
- CLDX 0.07
- Stochastic Oscillator
- ATRC 11.48
- CLDX 79.27
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.